Showing results (111-120 of 138) with videos related to
Sort By:
Pageof 14
Virology|September 1, 1994
The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathwayS L Hung, C Peng, I Kostavasili, et al.Journal of Virology|July 1, 1996
Immune evasion properties of herpes simplex virus type 1 glycoprotein gCH M Friedman, L Wang, N O Fishman, et al.The Journal of Experimental Medicine|August 1, 1983
Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutininG D Ross, S L Newman, J D Lambris, et al.European Journal of Immunology|November 1, 1991
Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21)I Esparza, J D Becherer, J Alsenz, et al.Nature Structural Biology|March 13, 1999
The molecular basis for protein kinase A anchoring revealed by solution NMRM G Newlon, M Roy, D Morikis, et al.The EMBO Journal|April 4, 2001
A novel mechanism of PKA anchoring revealed by solution structures of anchoring complexesM G Newlon, M Roy, D Morikis, et al.Transplantation|January 5, 2002
Human serum-induced expression of E-selectin on porcine aortic endothelial cells in vitro is totally complement mediatedU Ø Sølvik, G Haraldsen, A E Fiane, et al.Developmental and Comparative Immunology|May 18, 2001
Cloning and purification of the rainbow trout fifth component of complement (C5)S Franchini, I K Zarkadis, G Sfyroera, et al.Molecular Immunology|February 13, 2001
The three HveA receptor ligands, gD, LT-alpha and LIGHT bind to distinct sites on HveAM R Sarrias, J C Whitbeck, I Rooney, et al.Gene Therapy|March 12, 2010
An ex vivo loop system models the toxicity and efficacy of PEGylated and unmodified adenovirus serotype 5 in whole human bloodA Danielsson, G Elgue, B M Nilsson, et al.Pageof 14